Cyrille Lescop

USPTO Granted Patents = 12 (Patent Applications = 2)

CIPO Patents = 1

EPO Patents = 7 (Patent Applications = 7)

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 56(Granted Patents)

Location History:

Kembs, FR (2012 - 2013)
Allschil, CH (2014)
Allswchill, CH (2022)
Allschwil, CH (2015 - 2023)

Company Filing History:

8 out of 217

Actelion Pharmaceuticals Ltd

patents

4 out of 77

Idorsia Pharmaceuticals Ltd

patents

Years Active: 2012-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11834443 - Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol (2023-12-05),

2. 11390615 - Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenox (2022-07-19),

3. 10836754 - Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol (2020-11-17),

4. 10385043 - Crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol (2019-08-20),

5. 9617250 - Pyridin-4-yl derivatives (2017-04-11),

6. 9133179 - 2-methoxy-pyridin-4-yl-derivatives (2015-09-15),

7. 8658675 - Pyridin-4-yl derivatives (2014-02-25),

8. 8598208 - Pyridine derivatives as S1P1/EDG1 receptor modulators (2013-12-03),

9. 8575200 - Pyridin-2-yl derivatives as immunomodulating agents (2013-11-05),

10. 8410151 - Aminomethyl benzene derivatives (2013-04-02),

11. 8299086 - Pyrimidine derivatives (2012-10-30),

12. 8148410 - Thiophene derivatives as agonists of S1P1/EDG1 (2012-04-03),

Title: Cyrille Lescop: Innovator in Pharmaceutical Compounds

Introduction

Cyrille Lescop is a notable inventor based in Kembs, France, recognized for his contributions to the field of pharmaceuticals. With a total of 12 patents to his name, he has made significant advancements in the development of crystalline forms of various compounds.

Latest Patents

Among his latest patents is a crystalline form of the compound (S)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol. This invention relates to a specific crystalline form that enhances the properties of the compound, potentially leading to improved therapeutic applications.

Career Highlights

Cyrille Lescop has worked with prominent companies in the pharmaceutical industry, including Actelion Pharmaceuticals Ltd and Idorsia Pharmaceuticals Ltd. His work in these organizations has contributed to the development of innovative treatments and compounds.

Collaborations

Throughout his career, Cyrille has collaborated with esteemed colleagues such as Martin Bolli and Oliver Nayler, further enriching his contributions to the field.

Conclusion

Cyrille Lescop's work in the pharmaceutical sector exemplifies the impact of innovation on healthcare. His patents and collaborations highlight his commitment to advancing medical science through inventive solutions.

This text is generated by artificial intelligence and may not be accurate.